Featured Industry Insights
“I’ve Never Seen Anything as Effective”: Exploring the Combination of Psychedelics and Psychotherapy
While most psychedelic drugs remain illegal in the United States, ketamine has been legal for use by registered practitioners since the 1960s. With the recent recognition of the compound’s use as an antidepressant, more and more clinics are rolling out ketamine-assisted psychotherapy programs.
MEG Neuroimaging: The Magnetic Might Keeping Time on the Brain’s Hidden Secrets
Magnetoencephalography (MEG) is a neuroimaging technique that peers inside the brain by detecting incredibly weak magnetic signals produced by neurons. We spoke with Dimitrios Pantazis, who is director of the MEG lab at the Institute’s Martinos Imaging Center, to find out more about this powerful technology.
Latest Industry Insights
Nice to hear it’s not just me……
Although it has been a few years since I actually stepped foot in a lab to perform an actual, real-life experiment I still consider myself a scientist (and always will).
All SySTEMs go for Groundbreaking Cell Research
With all the hype surrounding the impending arrival of the first ‘stem cell burger’, stem cell research is once again hitting the headlines, but the focus of the public’s reaction has been more of curiosity than scepticism.
The Iceman’s DNA Cometh
Just wanted to leave you with short blog before the weekend…..
Great article on gene regulation at extreme altitudes
Hi, and welcome to our blogging site. Whilst doing a bit of research today, I came across this fascinating article on genetic responses to extreme altitudes. Expression profiling in 4 human subjects, by blood collection at varying altitudes, gave some exciting insights into the transcriptional regulatory landscape involved in the body’s overall coping mechanisms in such conditions. Of great interest is the unexpected role played by the OCT4 stem cell regulator gene.
It's Official...LABVANTAGE 6 Has Been Released!
JBoss Application Administration Training
An Instrument Interfacing Business Case: Interview with Hera Group
ESBB Inaugural Conference 2011
Biobanking - Collaborating for Global R&D and Investment